Serum Institute's Covovax approved for kids aged 7 to 11 years

Gallery

MORE...

Sports

Asian Games medallist Jyothi Yarraji to train in Spain ahead of Paris Olympics

Jyothi Yarraji, who won a silver medal in the 100m hurdles at the Hangzhou Asian Games, wi

Lione Messi said Retirement not on my mind

Indian Wells: Alcaraz, Swiatek win titles

African footballer chased and thrashed away in Kerala; reports

Hockey India announce core probable group for men's national camp in Bhubaneswar

Interim Budget: Large number of institutions of higher learning set up, highest ever medal tally in games reflects high confidence level, says FM

MORE...

Serum Institute's Covovax approved for kids aged 7 to 11 years

Last Updated : 28 Jun 2022 11:12:40 PM IST

India's apex drugs regulator, the Drugs Controller General of India (DCGI), on Tuesday approved Pune-based Serum Institute's Covid vaccine Covovax for children aged 7 to 11 years, as per a source.

The source said that SII's Covovax vaccine has been approved for restricted emergency use in children aged 7 to 11 years subject with certain conditions.

On June 24, the DCGI's Subject Expert Committee had recommended emergency use authorisation to Covovax vaccine for use in children aged 7-11.

As per the source, the DCGI has also approved India's first indigenously developed mRNA vaccine against Covid-19 manufactured by Gennova Biopharmaceuticals for restricted emergency use for those aged 18 years and above.

The DCGI had approved Covovax for restricted use in emergency situations in adults on December 28 and in the 12 to 17 years age group, subject to certain conditions, on March 9.